Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed…

By Florence Tubach, D. Salmon, P. Ravaud, Y. Allanore, P. Goupille, Maxime Breban, Béatrice Pallot-Prades, S. Pouplin, A. Sacchi, Rose Marie Chichemanian and 5 more. Arthritis & Rheumatism, 2009

665 citations recorded by the source corpus.

Subfields: Infectious Diseases, Rheumatology, Surgery

View Paper: https://www.semanticscholar.org/paper/44eb044a7770c46bc9e0b0f2f380bcf1fa450f91